News
-
-
-
REGULATED PRESS RELEASE
Disclosure of transactions in own shares from March 9 to March 13, 2026
-
-
-
-
-
-
PRESS RELEASE
Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Initiates Preclinical Study of Coca for Appetite Suppression
Magdalena Biosciences initiates preclinical study on whole leaf coca extract for appetite suppression post-GLP-1 weight loss. Study conducted in Alberta, Canada -